Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-23-010635

Director acquired 2,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Varian John Director 2023-02-02 Grant or award +2,500 4,400 D
Derivatives
Varian John Director 2023-02-02 Grant or award · Stock Option (Right to Buy) +9,500 9,500 D
Loading xslF345X03/tm235353d5_4seq1.xml…